Dong Ho Lee1, Jing Woong Kim2, Jeong Min Lee1,3, Jong Man Kim4, Min Woo Lee5, Hyunchul Rhim5, Young Hoe Hur6, Kyung-Suk Suh7. 1. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea. 2. Department of Radiology, Chosun University Hospital and Chosun University College of Medicine, Chosun, Republic of Korea. 3. Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. 4. Department of Surgery, Samsung Medical Center, Samsung, Republic of Korea. 5. Department of Radiology, Samsung Medical Center, Samsung, Republic of Korea. 6. Department of Hepato-Pancreato-Biliary Surgery, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Chonnam, Republic of Korea. 7. Department of Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Abstract
BACKGROUND: Treatment outcomes of laparoscopic liver resection (LLR) and percutaneous radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have not yet been fully compared. The aim of this study was to compare LLR and p-RFA as first-line treatment options in patients with single nodular HCCs ≤3 cm. METHODS: From January 2014 to December 2016, a total of 566 patients with single nodular HCC ≤3 cm treated by either LLR (n = 251) or p-RFA (n = 315) were included. The recurrence-free survival (RFS) and cumulative incidence of local tumor progression (LTP) were estimated using Kaplan-Meier methods and compared using the log-rank test. Treatment outcome of 2 treatment modalities was compared in the subgroup of patients according to the tumor location. RESULTS: There were no significant differences in overall survival between LLR and p-RFA (p = 0.160); however, 3-year RFS was demonstrated to be significantly higher after LLR (74.4%) than after p-RFA (66.0%) (p = 0.013), owing to its significantly lower cumulative incidence of LTP (2.1% at 3 years after LLR vs. 10.0% after p-RFA, p < 0.001). The complication rate of p-RFA was significantly lower than that of LLR (5.1 vs. 10.0%, p = 0.026). LLR also provided significantly better local tumor control than p-RFA for subscapular tumors (3-year LTP rates: 1.9 vs. 8.8%, p = 0.012), perivascular tumors (3-year LTP rates: 0.0 vs. 17.2%, p = 0.007), and tumors located in anteroinfero-lateral liver portions (3-year LTP rates: 0.0 vs. 10.7%, p < 0.001). However, there were no significant differences in LTP rates between LLR and p-RFA for non-subcapsular and non-perivascular tumors (p = 0.482) and for tumors in postero-superior liver portions (p = 0.380). CONCLUSIONS: LLR can provide significantly better local tumor control than p-RFA for small single HCCs in subcapsular, perivascular, and anteroinferolateral liver portions and thus may be the preferred treatment option for these tumors.
BACKGROUND: Treatment outcomes of laparoscopic liver resection (LLR) and percutaneous radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have not yet been fully compared. The aim of this study was to compare LLR and p-RFA as first-line treatment options in patients with single nodular HCCs ≤3 cm. METHODS: From January 2014 to December 2016, a total of 566 patients with single nodular HCC ≤3 cm treated by either LLR (n = 251) or p-RFA (n = 315) were included. The recurrence-free survival (RFS) and cumulative incidence of local tumor progression (LTP) were estimated using Kaplan-Meier methods and compared using the log-rank test. Treatment outcome of 2 treatment modalities was compared in the subgroup of patients according to the tumor location. RESULTS: There were no significant differences in overall survival between LLR and p-RFA (p = 0.160); however, 3-year RFS was demonstrated to be significantly higher after LLR (74.4%) than after p-RFA (66.0%) (p = 0.013), owing to its significantly lower cumulative incidence of LTP (2.1% at 3 years after LLR vs. 10.0% after p-RFA, p < 0.001). The complication rate of p-RFA was significantly lower than that of LLR (5.1 vs. 10.0%, p = 0.026). LLR also provided significantly better local tumor control than p-RFA for subscapular tumors (3-year LTP rates: 1.9 vs. 8.8%, p = 0.012), perivascular tumors (3-year LTP rates: 0.0 vs. 17.2%, p = 0.007), and tumors located in anteroinfero-lateral liver portions (3-year LTP rates: 0.0 vs. 10.7%, p < 0.001). However, there were no significant differences in LTP rates between LLR and p-RFA for non-subcapsular and non-perivascular tumors (p = 0.482) and for tumors in postero-superior liver portions (p = 0.380). CONCLUSIONS: LLR can provide significantly better local tumor control than p-RFA for small single HCCs in subcapsular, perivascular, and anteroinferolateral liver portions and thus may be the preferred treatment option for these tumors.
Authors: David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman Journal: AJR Am J Roentgenol Date: 2002-01 Impact factor: 3.959
Authors: Meidai Kasai; Federica Cipriani; Brice Gayet; Luca Aldrighetti; Francesca Ratti; Juan M Sarmiento; Olivier Scatton; Ki-Hun Kim; Ibrahim Dagher; Baki Topal; John Primrose; Takeo Nomi; David Fuks; Mohammad Abu Hilal Journal: Surgery Date: 2018-03-16 Impact factor: 3.982
Authors: David S K Lu; Steven S Raman; Piyaporn Limanond; Donya Aziz; James Economou; Ronald Busuttil; James Sayre Journal: J Vasc Interv Radiol Date: 2003-10 Impact factor: 3.464
Authors: Yun Seok Suh; Jae Won Choi; Jeong Hee Yoon; Dong Ho Lee; Yoon Jun Kim; Jeong Hoon Lee; Su Jong Yu; Eun Ju Cho; Jung Hwan Yoon; Jeong Min Lee Journal: Korean J Radiol Date: 2021-09-24 Impact factor: 3.500